Drug Profile
Cadrofloxacin
Alternative Names: CS 940Latest Information Update: 26 Jun 2007
Price :
$50
*
At a glance
- Originator Sankyo; Ube Industries
- Developer Sankyo
- Class Antibacterials; Quinolones; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections